Clinical Trials Browser

Adrenal Cortex Neoplasms, Adrenal Gland Neoplasms, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neuroblastoma, Paraganglioma, Pheochromocytoma, Recurrence, Osteosarcoma, Sarcoma, Synovial, Esthesioneuroblastoma, Olfactory, Neuroendocrine Tumors

Clinical Trials

LUPARPED

STAR-GBM

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

SELECT-2CAR

Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)

HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM

HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM)

PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications

ADVICE

Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma

NAVIG-1

SELECT-CAR-NK

EBNK-ST-001

5G-PEARL

Study of Pembrolizumab and M032 (NSC 733972)

5G-RUBY

A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma

Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma

Clinical Study of Oncolytic Virus in Glioblastoma

Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

RABBIT

Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells

D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients

Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

DLL3 CAR-T Therapy Targeting Brain Tumors

A Dose-escalation Clinical Study of Intraoperative Photodynamic Therapy of Glioblastoma

A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma

Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma

IA Carboplatin + Radiotherapy in Relapsing GBM

PAZOGLIO

Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA

Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma

CAPTEM

Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects

Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma

ALA-RDTinGBM

Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas

BAH2472

TCaP

GLUGLIO

GLIOSTAR

GLIOSUN